ReviewTropical animal health and production2021
A comprehensive review on avian chlamydiosis: a neglected zoonotic disease.
Review in Tropical animal health and production, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 2 syntheses or guidelines pooled it, 74 citations in OpenAlex.
- Global prevalence of psittacosis in outbreaks: a systematic review and meta-analysis.BMC public health · 2025Pooled it
- Clinical features and prognostic predictors of C. Psittaci Pneumonia: a systematic review and individual patient meta-analysis.BMC pulmonary medicine · 2025Pooled it
- Chlamydia psittaci Meningitis, Chile, 2023.Emerging infectious diseases · 2026Article
- A 9-year retrospective mortality review of captive orange-bellied parrots (Neophema chrysogaster) in Australia.Australian veterinary journal · 2026Article
- Hotspot or blind spot? Fine-scale spatial heterogeneity and methodological bias inOne health (Amsterdam, Netherlands) · 2026Article
- Molecular detection of Chlamydia psittaci in wild birds, broiler chickens, and sheep in Egypt: a public health concern.BMC veterinary research · 2026Article
- Clinical Features of 186 Cases ofInfection and drug resistance · 2026Article
- Clinical Features and Risk Factors for Severe Disease in 57 Cases ofInfection and drug resistance · 2026Article
- Long-Term Surveillance ofMicroorganisms · 2025Article
- Complete genomes of twoMicrobiology resource announcements · 2025Article
- Prevalence and Genetic Characteristics of Avian Chlamydia in Birds in Guangxi, Southwestern China.Microorganisms · 2025Article
- A review of zoonotic chlamydiae species in Africa: assessing their burden and potential impact through One Health perspective.One health outlook · 2025Review
- Review of respiratory syndromes in poultry: pathogens, prevention, and control measures.Veterinary research · 2025Review
- Psittacosis in Focus: A Review Addressing the Risks and Management Challenges in Outbreak Scenarios.Health science reports · 2025Article
- Chlamydia in farms located in the Argentine-Brazilian-Paraguay tri-border.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025Article
- Community-AcquiredCase reports in infectious diseases · 2025Article
- Assessment of Antimicrobial Therapy in Eradicating Chlamydia muridarum in Research Mice: Immune Status and Its Impact on Outcomes.Journal of the American Association for Laboratory Animal Science : JAALAS · 2025Article
- Addressing the resurgence of psittacosis: a call for enhanced surveillance and public health measures.Annals of medicine and surgery (2012) · 2025Article
- Zoonotic potential ofFrontiers in veterinary science · 2025Article
- Spatial analysis and prediction of psittacosis in Zhejiang Province, China, 2019-2024.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Avian chlamydiosis is one of the important neglected diseases with critical zoonotic potential. Chlamydia psittaci, the causative agent, affects most categories of birds, livestock, companion animals, and humans. It has many obscured characters and epidemiological dimensions, which makes it unique among other bacterial agents. Recent reports on transmission from equine to humans alarmed the public health authorities, and it necessitates the importance of routine screening of this infectious disease. High prevalence of spill-over infection in equines was associated with reproductive losses. Newer avian chlamydial species are being reported in the recent years. It is a potential biological warfare agent and the disease is an occupational hazard mainly to custom officers handling exotic birds. Prevalence of the disease in wild birds, pet birds, and poultry causes economic losses to the poultry industry and the pet bird trade. Interestingly, there are speculations on the 'legal' and 'illegal' bird trade that may be the global source of some of the most virulent strains of this pathogen. The mortality rate generally ranges from 5 to 40% in untreated cases, but it can sometimes be higher in co-infection. The intracellular lifestyle of this pathogen makes the diagnosis more complicated and there is also lack of accurate diagnostics. Resistance to antibiotics is reported only in some pathogens of the Chlamydiaceae family, but routine screening may assess the actual situation in all pathogens. Due to the diverse nature of the pathogen, the organism necessitates the One Health partnerships to have complete understanding. The present review focuses on the zoonotic aspects of avian chlamydiosis with its new insights into the pathogenesis, transmission, treatment, prevention, and control strategies. The review also briefs on the basic understandings and complex epidemiology of avian chlamydiosis, highlighting the need for research on emerging one health perspectives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.